Extravasation steps in breast cancer brain metastasis
Schematic representation of extravasation steps in breast cancer brain metastasis. (A) Rolling and firm adhesion: Rolling and firm adhesion are the first two steps occurring during extravasation, in which ligands expressed on breast cancer cells interact with respective molecules expressed on BECs. During rolling, breast cancer cells express ligands, including PSGL-1, CD24, sLex, and MUC1 that interact with endothelial E-selectin. During adhesion, additional ligands expressed on breast cancer cells, including CD44, MUC1, LFA-1 (Integrin αLβ2), VLA-4 (Integrin α4β1), ALCAM, and Integrin β4, interact with adhesion molecules expressed on the BEC, including VCAM-1 and ICAM-1 to allow the firm adhesion of breast cancer cells on the BEC [28,29]. Mechanistically, through the inflammation and upregulation of PI3K/AKT, Rac signaling pathways have been shown to induce expression of adhesion molecules and promote the adhesion of breast cancer cells on the BE [74]. (B) Trans-endothelial migration: Enhanced permeability of BBB in breast cancer BM is mediated by upregulation of inflammatory mediators, including the COX2 and MMPs, leading to the disruption of inter-endothelial junctions, including (ZO-1 and claudin-5) [43]. Upregulation of CXCR4/SDF1 signaling pathway induces vascular permeability and TEM through activating PI3K/AKT and calcium signaling [73]. Upregulation of VEGF increases the permeability of BBB through redistributing actin fiber and disrupting VE-cadherin, thus promoting TEM. Cathepsin-S induces proteolytic cleavage of JAM-B, ADAM8 upregulates MMP9, and EndMT decreases VE-cadherin levels. Other mediators of breast cancer cells TEM include VEGF, MMP1, ST6GALNAC5, COX2, HB-EGF, GBP1, Sema4D, HER2, HPSE, CXCR4/SDF1, PI3K/AKT, Sdcs-1, and Cx43. Pericytes exert a chemoattractant effect on breast cancer cells to promote TEM [38]. Photo created with BioRender.com.
Publication
Insights into the Molecular Mechanisms Mediating Extravasation in Brain Metastasis of Breast Cancer, Melanoma, and Lung Cancer (2023) Rama Alsabbagh, et al. Cancers (Basel). 2023 Apr;15(8). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | COX-2 | COX-2 | ncbigene_synonym | PTGS2 | 5743 |
| Homo sapiens | Primates | CD44 | CD44 | ncbigene_symbol | CD44 | 960 |
| Homo sapiens | Primates | PSGL-1 | PSGL-1 | ncbigene_synonym | SELPLG | 6404 |
| Homo sapiens | Primates | VEGF | VEGF | ncbigene_synonym | VEGFA | 7422 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFB | 7423 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFC | 7424 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | VEGFD | 2277 |
| Homo sapiens | Primates | VEGF | VEGF | famplex_relations | PGF | 5228 |
| Homo sapiens | Primates | MUC1 | MUC1 | ncbigene_symbol | MUC1 | 4582 |
| Homo sapiens | Primates | CD24 | CD24 | ncbigene_symbol | CD24 | 100133941 |
| Homo sapiens | Primates | SDF-1 | SDF1 | ncbigene_synonym | CXCL12 | 6387 |
| Homo sapiens | Primates | AKT | AKT | ncbigene_synonym | AKT1 | 207 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT2 | 208 |
| Homo sapiens | Primates | AKT | AKT | famplex_relations | AKT3 | 10000 |
| Homo sapiens | Primates | CXCR4 | CXCR4 | ncbigene_symbol | CXCR4 | 7852 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CA | 5290 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CB | 5291 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CD | 5293 |
| Homo sapiens | Primates | PI3K | PI3K | ncbigene_synonym | PIK3CG | 5294 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R3 | 8503 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R4 | 30849 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R5 | 23533 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R6 | 146850 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R1 | 5295 |
| Homo sapiens | Primates | PI3K | PI3K | famplex_relations | PIK3R2 | 5296 |
| Homo sapiens | Primates | Ang-2 | ANG2 | ncbigene_synonym | ANGPT2 | 285 |
| Homo sapiens | Primates | Ang-2 | ANG2 | ncbigene_synonym | VPS51 | 738 |
| Homo sapiens | Primates | TNF-a | TNF-A | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | ALCAM | ALCAM | ncbigene_symbol | ALCAM | 214 |
| Homo sapiens | Primates | MMP1 | MMP1 | ncbigene_symbol | MMP1 | 4312 |
| Homo sapiens | Primates | ST6GALNAC5 | ST6GALNAC5 | ncbigene_symbol | ST6GALNAC5 | 81849 |
| Homo sapiens | Primates | HPSE | HPSE | ncbigene_symbol | HPSE | 10855 |
| Homo sapiens | Primates | MMP9 | MMP9 | ncbigene_symbol | MMP9 | 4318 |
| Homo sapiens | Primates | ADAM8 | ADAM8 | ncbigene_symbol | ADAM8 | 101 |
| Homo sapiens | Primates | TGF-B1 | TGF-B1 | ncbigene_synonym | TGFB1 | 7040 |
| Homo sapiens | Primates | ↑PI3K/AKT,Rac | RAC | famplex_relations | RAC1 | 5879 |
| Homo sapiens | Primates | ↑PI3K/AKT,Rac | RAC | famplex_relations | RAC2 | 5880 |
| Homo sapiens | Primates | ↑PI3K/AKT,Rac | RAC | famplex_relations | RAC3 | 5881 |
| Homo sapiens | Primates | ↑PI3K/AKT,Rac | RAC | famplex_relations | RHOG | 391 |
| Homo sapiens | Primates | Mfsd2a | MFSD2A | ncbigene_symbol | MFSD2A | 84879 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | CYLD | 1540 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | TNMD | 64102 |
| Homo sapiens | Primates | TEM | TEM | ncbigene_synonym | MFT2 | 100188881 |
| Homo sapiens | Primates | HBEGF | HBEGF | ncbigene_symbol | HBEGF | 1839 |
| Homo sapiens | Primates | COX-2; | COX2 | ncbigene_symbol | COX2 | 4513 |
| Homo sapiens | Primates | COX-2; | COX2 | ncbigene_synonym | MTCO2P12 | 107075310 |
| Homo sapiens | Primates | GBP1; | GBP1 | ncbigene_symbol | GBP1 | 2633 |
| Homo sapiens | Primates | Sema4D | SEMA4D | ncbigene_symbol | SEMA4D | 10507 |
| Homo sapiens | Primates | HER-2; | HER2 | ncbigene_synonym | ERBB2 | 2064 |
| Homo sapiens | Primates | +Cx43 | CX43 | ncbigene_synonym | GJA1 | 2697 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| sLex | sLeX | 5-acetamido-3,5-dideoxy-D-glycero-alpha-D-galacto-non-2-ulopyranonosyl-(2->3)-beta-D-galactopyranosyl-(1->4)-[alpha-L-fucopyranosyl-(1->3)]-2-acetamido-2-deoxy-D-glucopyranose | chebi:61711 |